Skip to main content
Curiox Biosystems Co., Ltd. logo

Curiox Biosystems Co., Ltd. — Investor Relations & Filings

Ticker · 445680 ISIN · KR7445680002 KO Manufacturing
Open in API
Filings indexed 130 across all filing types
Latest filing 2024-03-18 Audit Report / Informat…
Country KR South Korea
Listing KO 445680

About Curiox Biosystems Co., Ltd.

https://www.curiox.com/

Curiox Biosystems is a life science technology company that develops and manufactures automated solutions for cell sample preparation. The company specializes in centrifuge-free technologies designed to standardize and improve workflows for cell analysis. Its core C-FREE™ technology utilizes a gentle, laminar flow-based washing method that replaces traditional centrifugation. This approach minimizes cell stress and loss, thereby enhancing cell retention, viability, and the quality of downstream analytical data. Curiox's product portfolio includes the Pluto series of automated liquid handling workstations and associated consumables. These systems automate critical steps such as cell washing, antibody staining, and antibody cocktailing for applications including flow cytometry, single-cell sequencing, and multiplex immunoassays, supporting research with various sensitive cell types.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 100% confidence The document is a regulatory filing from a Korean company (Curiox Biosystems) titled 'Audit Report Submission' (감사보고서 제출). It provides a summary of the audit opinion (unqualified/proper), key financial data (assets, liabilities, equity, profit/loss), and details regarding the auditor. According to the 'Menu vs Meal' rule, this is an announcement of the audit report submission rather than the full, multi-page audit report document itself. In the context of Korean regulatory filings (DART system), this specific format is classified as a Report Publication Announcement (RPA). FY 2023
2024-03-18 Korean
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) issued by Curiox Biosystems. It contains the meeting agenda, details on voting procedures, director information, and financial statements for shareholder approval. This type of document is classified as a Proxy Solicitation & Information Statement (PSI) because it provides shareholders with the necessary information to vote on company matters at the upcoming meeting.
2024-03-13 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for Curiox Biosystems. It outlines the date, location, agenda items (such as financial statement approval, director appointments, and remuneration limits), and details regarding the proposed board members. This document is a standard proxy solicitation/information statement provided to shareholders to inform them of the upcoming meeting and the matters to be voted upon.
2024-02-07 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Supervisory Service (FSS) in South Korea. It details changes in share ownership by Luha Private Equity Inc. in Curiox Biosystems. This type of filing is a regulatory requirement for entities crossing significant ownership thresholds (often referred to as 5% rule filings). In the provided classification schema, 'Major Shareholding Notification' (MRQ) is the correct category for filings that report changes in significant share ownership levels.
2023-12-20 Korean
주주명부폐쇄기간또는기준일설정
Notice of Dividend Amount Classification · 95% confidence The document is a short regulatory notice regarding the setting of a record date for the purpose of determining shareholders eligible to vote at the upcoming Annual General Meeting (AGM). It does not contain the full report or proxy materials themselves, but rather serves as a formal regulatory notification of a corporate action. Given the nature of the announcement and the lack of a specific category for 'Record Date' notices, it falls under the general regulatory filing category.
2023-12-15 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean regulatory authorities (Financial Supervisory Service/Korea Exchange). It details the share ownership changes of a specific executive (Jung, HongTae) of Curiox Biosystems. This type of filing is classified as a 'Director's Dealing' (DIRS) as it reports personal share transactions by company directors/executives.
2023-12-13 Korean

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.